Substance / Medication

Terazosin hydrochloride anhydrous

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

4 trials linked to this intervention

4
Total Trials
1
Recruiting
2
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Risk factors for postpartum urinary retention: An updated systematic review and meta-analysis.
Li Li, Chen Qin, Li Hongyu et al. · Int J Gynaecol Obstet · 2025
PMID: 39049607Meta-Analysis
Complication rate across the minimally invasive surgical treatments (MISTs): where do we stand? A systematic review of the literature.
Lambertini Luca, Sandulli Alessandro, Coco Simone et al. · Prostate Cancer Prostatic Dis · 2025
PMID: 39438691Meta-Analysis
Prostatic stents: a systematic review and analysis of functional outcomes and complication rate.
Cerrato Clara, Antoniou Vaki, Somani Bhaskar Kumar · Prostate Cancer Prostatic Dis · 2025
PMID: 39516581Meta-Analysis
Acupuncture treatment of postoperative urinary retention in cervical cancer: Systematic evaluation and meta-analysis.
Xu Hui, He Yujun, Miao Furui et al. · Medicine (Baltimore) · 2025
PMID: 39993070Meta-AnalysisFull text (PMC)
Variation in Defining Retention After Onabotulinum Toxin A for Overactive Bladder: A Systematic Review.
Castaneda Peris R, Chen Andrew, Kuhlmann Paige et al. · Urogynecology (Phila) · 2024
PMID: 38465990Meta-Analysis
Active Compared With Passive Voiding Trials After Midurethral Sling Surgery: A Systematic Review.
Drangsholt Siri, Lleras Cassidy, Kindler Rebecca et al. · Obstet Gynecol · 2024
PMID: 38547487Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Terazosin hydrochloride anhydrous (substance)
SNOMED CT
1269092006
UMLS CUI
C2241271

Clinical Data

This intervention maps to 8 entities in the Healos knowledge graph.

4
Conditions
1
Biomarkers
2
Specialists
0
Symptoms
4
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.